Evidence map›Paper›PMID 26554541›Full record

ArticleArthritis & rheumatology (Hoboken, N.J.)2016

Production of RANKL by Memory B Cells: A Link Between B Cells and Bone Erosion in Rheumatoid Arthritis.

Nida Meednu, Hengwei Zhang, Teresa Owen, Wen Sun, Victor Wang, Christopher Cistrone, Javier Rangel-Moreno, Lianping Xing, Jennifer H Anolik

Open access · greenAbstract read
In one paragraph

Article in Arthritis & rheumatology (Hoboken, N.J.), 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 104 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
104citing papers in PubMed, 1 pooled it
6.8field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

104 citing papers in PubMed, 1 synthesis or guideline pooled it, 181 citations in OpenAlex.

  1. Pooled it
  2. [Mechanism of Qingluo Tongbi Formula for regulating immune-bone erosion in rheumatoid arthritis].Nan fang yi ke da xue xue bao = Journal of Southern Medical University · 2023
    Trial
  3. Trial
  4. Article
  5. Article
  6. Article
  7. A RANKLBone research · 2026
    Article
  8. Review
  9. Article
  10. Review
  11. Article
  12. Article
  13. Review
  14. Review
  15. Review
  16. Article
  17. Article
  18. Review
  19. Review
  20. Article

44 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Nida MeednuUniversity of Rochester Medical Center, Rochester, New York.
Hengwei ZhangUniversity of Rochester Medical Center, Rochester, New York.
Teresa OwenUniversity of Rochester Medical Center, Rochester, New York.
Wen SunUniversity of Rochester Medical Center, Rochester, New York.
Victor WangUniversity of Rochester Medical Center, Rochester, New York.
Christopher CistroneUniversity of Rochester Medical Center, Rochester, New York.
Javier Rangel-MorenoUniversity of Rochester Medical Center, Rochester, New York.
Lianping XingUniversity of Rochester Medical Center, Rochester, New York.
Jennifer H AnolikUniversity of Rochester Medical Center, Rochester, New York.
University of Rochester Medical Center · US

Funding

Role of B Cells in Synovial Inflammation & LN Remodeling in RA ArthritisP01AI078907 · NIAID · UNIVERSITY OF ROCHESTER · PI WU, HULIN · 2010 to 2014
$10.8M
Cellular Dynamics at the Synovium-Bone interface in RAUH2AR067690 · NIAMS · UNIVERSITY OF ROCHESTER · PI ANOLIK, JENNIFER HOWITT · 2014 to 2020
$3.0M
Role of TNFalpha in Osteoclast-Mediated Bone LossR01AR048697 · NIAMS · UNIVERSITY OF ROCHESTER · PI XING, LIANPING · 2002 to 2012
$2.6M
Study of osteoblast regulation in TNF-mediated bone lossR01AR063650 · NIAMS · UNIVERSITY OF ROCHESTER · PI XING, LIANPING · 2013 to 2016
$1.4M
NIAID NIH HHS P01 AI078907NIAID NIH HHS P01-AI-078907NIAID NIH HHS U19-AI-563262NIAMS NIH HHS AR-48697NIAMS NIH HHS AR-63650NIAMS NIH HHS R01 AR048697NIAMS NIH HHS R01 AR063650NIAMS NIH HHS UH2 AR067690
6 · The paper itself

Abstract

objectiveRheumatoid arthritis (RA) is a systemic autoimmune disease that often leads to joint damage. The mechanisms of bone damage in RA are complex, involving activation of bone-resorbing osteoclasts (OCs) by synoviocytes and Th17 cells. This study was undertaken to investigate whether B cells play a direct role in osteoclastogenesis through the production of RANKL, the essential cytokine for OC development.

methodsRANKL production by total B cells or sorted B cell subpopulations in the peripheral blood and synovial tissue from healthy donors or anti-cyclic citrullinated peptide-positive patients with RA was examined by flow cytometry, real-time polymerase chain reaction, enzyme-linked immunosorbent assay, and immunohistochemical analysis. To define direct effects on osteoclastogenesis, B cells were cocultured with CD14+ monocytes, and OCs were enumerated by tartrate-resistant acid phosphatase staining.

resultsHealthy donor peripheral blood B cells were capable of expressing RANKL upon stimulation, with switched memory B cells (CD27+IgD-) having the highest propensity for RANKL production. Notably, switched memory B cells in the peripheral blood from RA patients expressed significantly more RANKL compared to healthy controls. In RA synovial fluid and tissue, memory B cells were enriched and spontaneously expressed RANKL, with some of these cells visualized adjacent to RANK+ OC precursors. Critically, B cells supported OC differentiation in vitro in a RANKL-dependent manner, and the number of OCs was higher in cultures with RA B cells than in those derived from healthy controls.

conclusionThese findings reveal the critical importance of B cells in bone homeostasis and their likely contribution to joint destruction in RA.

Indexed as

Acid PhosphataseArthritis, RheumatoidB-LymphocytesBone ResorptionCase-Control StudiesCell DifferentiationEnzyme-Linked Immunosorbent AssayFlow CytometryHumansImmunohistochemistryIn Vitro TechniquesIsoenzymesMonocytesOsteoclastsRANK LigandReal-Time Polymerase Chain ReactionAcid PhosphataseIsoenzymesRANK LigandRNA, MessengerTartrate-Resistant Acid PhosphataseTNFSF11 protein, human

Identifiers

PMID26554541
PMCPMC4956406
OpenAlexW2403038751

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.